 | • レポートコード：MRC2-11QY01524 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は低酸素誘導因子1アルファ阻害剤のグローバル市場について調査・分析したレポートです。種類別（BC-001、CASI-2ME2、CRLX-101、その他）市場規模、用途別（固形腫瘍、急性骨髄性白血病、結腸直腸癌、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別低酸素誘導因子1アルファ阻害剤の競争状況、市場シェア ・世界の低酸素誘導因子1アルファ阻害剤市場：種類別市場規模 2015年-2020年（BC-001、CASI-2ME2、CRLX-101、その他） ・世界の低酸素誘導因子1アルファ阻害剤市場：種類別市場規模予測 2021年-2026年（BC-001、CASI-2ME2、CRLX-101、その他） ・世界の低酸素誘導因子1アルファ阻害剤市場：用途別市場規模 2015年-2020年（固形腫瘍、急性骨髄性白血病、結腸直腸癌、その他） ・世界の低酸素誘導因子1アルファ阻害剤市場：用途別市場規模予測 2021年-2026年（固形腫瘍、急性骨髄性白血病、結腸直腸癌、その他） ・北米の低酸素誘導因子1アルファ阻害剤市場分析：米国、カナダ ・ヨーロッパの低酸素誘導因子1アルファ阻害剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの低酸素誘導因子1アルファ阻害剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の低酸素誘導因子1アルファ阻害剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの低酸素誘導因子1アルファ阻害剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aileron Therapeutics, Inc.、CASI Pharmaceuticals Inc.、Cerulean Pharma, Inc.、F. Hoffmann-La Roche Ltd.、InterMed Discovery GmbH、OncoImmune, Inc.、Peloton Therapeutics, Inc.、RXi Pharmaceuticals Corporation、Sorrento Therapeutics, Inc.、Transcriptogen Ltd、Vascular Biogenics Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market
The global Hypoxia Inducible Factor 1 Alpha Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hypoxia Inducible Factor 1 Alpha Inhibitor Scope and Market Size
Hypoxia Inducible Factor 1 Alpha Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hypoxia Inducible Factor 1 Alpha Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hypoxia Inducible Factor 1 Alpha Inhibitor market is segmented into
BC-001
CASI-2ME2
CRLX-101
Others
Segment by Application, the Hypoxia Inducible Factor 1 Alpha Inhibitor market is segmented into
Solid Tumor
Acute Myelocytic Leukemia
Colorectal Cancer
Others
Regional and Country-level Analysis
The Hypoxia Inducible Factor 1 Alpha Inhibitor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hypoxia Inducible Factor 1 Alpha Inhibitor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share Analysis
Hypoxia Inducible Factor 1 Alpha Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hypoxia Inducible Factor 1 Alpha Inhibitor business, the date to enter into the Hypoxia Inducible Factor 1 Alpha Inhibitor market, Hypoxia Inducible Factor 1 Alpha Inhibitor product introduction, recent developments, etc.
The major vendors covered:
Aileron Therapeutics, Inc.
CASI Pharmaceuticals Inc.
Cerulean Pharma, Inc.
F. Hoffmann-La Roche Ltd.
InterMed Discovery GmbH
OncoImmune, Inc.
Peloton Therapeutics, Inc.
RXi Pharmaceuticals Corporation
Sorrento Therapeutics, Inc.
Transcriptogen Ltd
Vascular Biogenics Ltd.
1 Study Coverage
1.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction
1.2 Market Segments
1.3 Key Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Growth Rate by Type
1.4.2 BC-001
1.4.3 CASI-2ME2
1.4.4 CRLX-101
1.4.5 Others
1.5 Market by Application
1.5.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Growth Rate by Application
1.5.2 Solid Tumor
1.5.3 Acute Myelocytic Leukemia
1.5.4 Colorectal Cancer
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size, Estimates and Forecasts
2.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue 2015-2026
2.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales 2015-2026
2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Competitor Landscape by Players
3.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Manufacturers
3.1.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Manufacturers (2015-2020)
3.1.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Manufacturers (2015-2020)
3.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Manufacturers
3.2.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Manufacturers (2015-2020)
3.2.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue in 2019
3.2.5 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Manufacturers
3.4 Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base Distribution, Product Types
3.4.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hypoxia Inducible Factor 1 Alpha Inhibitor Product Type
3.4.3 Date of International Manufacturers Enter into Hypoxia Inducible Factor 1 Alpha Inhibitor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Type (2015-2020)
4.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2015-2020)
4.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type (2015-2020)
4.1.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast by Type (2021-2026)
4.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Application (2015-2020)
5.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2015-2020)
5.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Application (2015-2020)
5.1.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Application (2015-2020)
5.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast by Application (2021-2026)
5.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor by Country
6.1.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country
6.1.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Type
6.3 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Application
7 Europe
7.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor by Country
7.1.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country
7.1.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Type
7.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor by Region
8.1.1 Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region
8.1.2 Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Type
8.3 Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor by Country
9.1.1 Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country
9.1.2 Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Type
9.3 Central & South America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor by Country
10.1.1 Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country
10.1.2 Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Type
10.3 Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Market Facts & Figures by Application
11 Company Profiles
11.1 Aileron Therapeutics, Inc.
11.1.1 Aileron Therapeutics, Inc. Corporation Information
11.1.2 Aileron Therapeutics, Inc. Description and Business Overview
11.1.3 Aileron Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.1.5 Aileron Therapeutics, Inc. Related Developments
11.2 CASI Pharmaceuticals Inc.
11.2.1 CASI Pharmaceuticals Inc. Corporation Information
11.2.2 CASI Pharmaceuticals Inc. Description and Business Overview
11.2.3 CASI Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.2.5 CASI Pharmaceuticals Inc. Related Developments
11.3 Cerulean Pharma, Inc.
11.3.1 Cerulean Pharma, Inc. Corporation Information
11.3.2 Cerulean Pharma, Inc. Description and Business Overview
11.3.3 Cerulean Pharma, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.3.5 Cerulean Pharma, Inc. Related Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.4.5 F. Hoffmann-La Roche Ltd. Related Developments
11.5 InterMed Discovery GmbH
11.5.1 InterMed Discovery GmbH Corporation Information
11.5.2 InterMed Discovery GmbH Description and Business Overview
11.5.3 InterMed Discovery GmbH Sales, Revenue and Gross Margin (2015-2020)
11.5.4 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.5.5 InterMed Discovery GmbH Related Developments
11.6 OncoImmune, Inc.
11.6.1 OncoImmune, Inc. Corporation Information
11.6.2 OncoImmune, Inc. Description and Business Overview
11.6.3 OncoImmune, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.6.5 OncoImmune, Inc. Related Developments
11.7 Peloton Therapeutics, Inc.
11.7.1 Peloton Therapeutics, Inc. Corporation Information
11.7.2 Peloton Therapeutics, Inc. Description and Business Overview
11.7.3 Peloton Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.7.5 Peloton Therapeutics, Inc. Related Developments
11.8 RXi Pharmaceuticals Corporation
11.8.1 RXi Pharmaceuticals Corporation Corporation Information
11.8.2 RXi Pharmaceuticals Corporation Description and Business Overview
11.8.3 RXi Pharmaceuticals Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.8.5 RXi Pharmaceuticals Corporation Related Developments
11.9 Sorrento Therapeutics, Inc.
11.9.1 Sorrento Therapeutics, Inc. Corporation Information
11.9.2 Sorrento Therapeutics, Inc. Description and Business Overview
11.9.3 Sorrento Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.9.5 Sorrento Therapeutics, Inc. Related Developments
11.10 Transcriptogen Ltd
11.10.1 Transcriptogen Ltd Corporation Information
11.10.2 Transcriptogen Ltd Description and Business Overview
11.10.3 Transcriptogen Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.10.5 Transcriptogen Ltd Related Developments
11.1 Aileron Therapeutics, Inc.
11.1.1 Aileron Therapeutics, Inc. Corporation Information
11.1.2 Aileron Therapeutics, Inc. Description and Business Overview
11.1.3 Aileron Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered
11.1.5 Aileron Therapeutics, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Estimates and Projections by Region
12.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Regions 2021-2026
12.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Regions 2021-2026
12.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast (2021-2026)
12.2.1 North America: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast (2021-2026)
12.2.2 North America: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast (2021-2026)
12.2.3 North America: Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast by Country (2021-2026)
12.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast (2021-2026)
12.3.1 Europe: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast (2021-2026)
12.3.2 Europe: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast (2021-2026)
12.3.3 Europe: Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast by Region (2021-2026)
12.5 Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast (2021-2026)
12.5.1 Latin America: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast (2021-2026)
12.5.2 Latin America: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast (2021-2026)
12.5.3 Latin America: Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hypoxia Inducible Factor 1 Alpha Inhibitor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hypoxia Inducible Factor 1 Alpha Inhibitor Market Segments
Table 2. Ranking of Global Top Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BC-001
Table 5. Major Manufacturers of CASI-2ME2
Table 6. Major Manufacturers of CRLX-101
Table 7. Major Manufacturers of Others
Table 8. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Regions (2015-2020)
Table 12. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Share by Manufacturers (2015-2020)
Table 15. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Hypoxia Inducible Factor 1 Alpha Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoxia Inducible Factor 1 Alpha Inhibitor as of 2019)
Table 17. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Hypoxia Inducible Factor 1 Alpha Inhibitor Price (2015-2020) (USD/Pcs)
Table 20. Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Hypoxia Inducible Factor 1 Alpha Inhibitor Product Type
Table 22. Date of International Manufacturers Enter into Hypoxia Inducible Factor 1 Alpha Inhibitor Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2015-2020) (K Pcs)
Table 25. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Share by Type (2015-2020)
Table 26. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Share by Type (2015-2020)
Table 28. Hypoxia Inducible Factor 1 Alpha Inhibitor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2015-2020) (K Pcs)
Table 30. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Share by Application (2015-2020)
Table 31. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2015-2020) (K Pcs)
Table 32. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2015-2020)
Table 33. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2015-2020)
Table 35. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2015-2020) (K Pcs)
Table 36. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2015-2020)
Table 37. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2015-2020) (K Pcs)
Table 38. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2015-2020)
Table 39. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2015-2020)
Table 41. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2015-2020)
Table 43. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2015-2020)
Table 45. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2015-2020)
Table 55. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2015-2020)
Table 59. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2015-2020)
Table 61. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2015-2020)
Table 71. Aileron Therapeutics, Inc. Corporation Information
Table 72. Aileron Therapeutics, Inc. Description and Major Businesses
Table 73. Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Aileron Therapeutics, Inc. Product
Table 75. Aileron Therapeutics, Inc. Recent Development
Table 76. CASI Pharmaceuticals Inc. Corporation Information
Table 77. CASI Pharmaceuticals Inc. Description and Major Businesses
Table 78. CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. CASI Pharmaceuticals Inc. Product
Table 80. CASI Pharmaceuticals Inc. Recent Development
Table 81. Cerulean Pharma, Inc. Corporation Information
Table 82. Cerulean Pharma, Inc. Description and Major Businesses
Table 83. Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Cerulean Pharma, Inc. Product
Table 85. Cerulean Pharma, Inc. Recent Development
Table 86. F. Hoffmann-La Roche Ltd. Corporation Information
Table 87. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 88. F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. F. Hoffmann-La Roche Ltd. Product
Table 90. F. Hoffmann-La Roche Ltd. Recent Development
Table 91. InterMed Discovery GmbH Corporation Information
Table 92. InterMed Discovery GmbH Description and Major Businesses
Table 93. InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. InterMed Discovery GmbH Product
Table 95. InterMed Discovery GmbH Recent Development
Table 96. OncoImmune, Inc. Corporation Information
Table 97. OncoImmune, Inc. Description and Major Businesses
Table 98. OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. OncoImmune, Inc. Product
Table 100. OncoImmune, Inc. Recent Development
Table 101. Peloton Therapeutics, Inc. Corporation Information
Table 102. Peloton Therapeutics, Inc. Description and Major Businesses
Table 103. Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Peloton Therapeutics, Inc. Product
Table 105. Peloton Therapeutics, Inc. Recent Development
Table 106. RXi Pharmaceuticals Corporation Corporation Information
Table 107. RXi Pharmaceuticals Corporation Description and Major Businesses
Table 108. RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. RXi Pharmaceuticals Corporation Product
Table 110. RXi Pharmaceuticals Corporation Recent Development
Table 111. Sorrento Therapeutics, Inc. Corporation Information
Table 112. Sorrento Therapeutics, Inc. Description and Major Businesses
Table 113. Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Sorrento Therapeutics, Inc. Product
Table 115. Sorrento Therapeutics, Inc. Recent Development
Table 116. Transcriptogen Ltd Corporation Information
Table 117. Transcriptogen Ltd Description and Major Businesses
Table 118. Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Transcriptogen Ltd Product
Table 120. Transcriptogen Ltd Recent Development
Table 121. Vascular Biogenics Ltd. Corporation Information
Table 122. Vascular Biogenics Ltd. Description and Major Businesses
Table 123. Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Vascular Biogenics Ltd. Product
Table 125. Vascular Biogenics Ltd. Recent Development
Table 126. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 127. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. North America: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Europe: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Region (2021-2026) (K Pcs)
Table 135. Asia Pacific: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. Latin America: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Middle East and Africa: Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Hypoxia Inducible Factor 1 Alpha Inhibitor Players
Table 144. Hypoxia Inducible Factor 1 Alpha Inhibitor Customers List
Table 145. Hypoxia Inducible Factor 1 Alpha Inhibitor Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Picture
Figure 2. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. BC-001 Product Picture
Figure 4. CASI-2ME2 Product Picture
Figure 5. CRLX-101 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application in 2020 & 2026
Figure 8. Solid Tumor
Figure 9. Acute Myelocytic Leukemia
Figure 10. Colorectal Cancer
Figure 11. Others
Figure 12. Hypoxia Inducible Factor 1 Alpha Inhibitor Report Years Considered
Figure 13. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size 2015-2026 (US$ Million)
Figure 14. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales 2015-2026 (K Pcs)
Figure 15. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region (2015-2020)
Figure 17. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region in 2019
Figure 18. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Region (2015-2020)
Figure 19. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Region in 2019
Figure 20. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue in 2019
Figure 22. Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2015-2020)
Figure 24. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type in 2019
Figure 25. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Type (2015-2020)
Figure 26. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Type in 2019
Figure 27. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Price Range (2015-2020)
Figure 28. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2015-2020)
Figure 29. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application in 2019
Figure 30. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Application (2015-2020)
Figure 31. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Application in 2019
Figure 32. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country in 2019
Figure 35. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country in 2019
Figure 36. U.S. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Type in 2019
Figure 41. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application in 2019
Figure 42. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country in 2019
Figure 45. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country in 2019
Figure 46. Germany Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Type in 2019
Figure 57. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application in 2019
Figure 58. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region in 2019
Figure 61. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Region in 2019
Figure 62. China Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Type in 2019
Figure 85. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application in 2019
Figure 86. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country in 2019
Figure 89. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country in 2019
Figure 90. Mexico Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Type in 2019
Figure 97. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application in 2019
Figure 98. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country in 2019
Figure 102. Turkey Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Type in 2019
Figure 109. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application in 2019
Figure 110. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market The global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Inh…- 血管内皮増殖因子阻害薬の世界市場（～2026年） Market Analysis and Insights: Global Vascular Endothelial Growth Factor Inhibitor Market The global Vascular Endothelial Growth Factor Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vascular Endothelial Grow…
- 腫瘍壊死因子α阻害剤の世界市場（～2026年） The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), i…
- インテグリンアルファVの世界市場（～2026年） Market Analysis and Insights: Global Integrin Alpha V Market The global Integrin Alpha V market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Integrin Alpha V Scope and Market Size Integrin Alpha V market is segmented by Ty…
- 血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…